News from correvio pharma corp A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 08, 2019, 08:00 ET Correvio Reports First Quarter 2019 Financial Results

Mark H.N. Corrigan, MD Commences Role as CEO, effective March 14, 2019 Company on Track to Resubmit Brinavess NDA in Q2 2019 Management to Host...


May 01, 2019, 08:00 ET Correvio to Report First Quarter 2019 Financial Results on May 8, 2019

Conference Call Scheduled for Wednesday, May 8, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER, May 1, 2019...


Apr 03, 2019, 09:29 ET Correvio Announces Zevtera® Abstracts at ECCMID 2019

NASDAQ: CORV TSX: CORV Seven Data Abstracts Selected for Poster Presentations VANCOUVER, April 3, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ:...


Apr 03, 2019, 09:28 ET Correvio Announces Xydalba™ (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019

NASDAQ: CORV TSX: CORV Selected Data Abstracts for Presentation VANCOUVER, April 3, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX:...


Apr 02, 2019, 08:00 ET Correvio to present at the H.C. Wainwright Global Life Sciences Conference

NASDAQ: CORV TSX: CORV VANCOUVER, April 2, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company...


Mar 20, 2019, 08:00 ET Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting

Data Will Also Be Presented at the Upcoming 23rd Israeli Congress for Emergency Medicine NASDAQ: CORV TSX: CORV VANCOUVER, March 20, 2019...


Mar 14, 2019, 07:00 ET Correvio Announces at the Market Offering

NASDAQ: CORV TSX: CORV VANCOUVER, March 14, 2019 /PRNewswire/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), ("Correvio" or the "Company"), a...


Mar 13, 2019, 07:00 ET Correvio Reports Fourth Quarter and Full Year 2018 Financial Results

Company on Track to Resubmit Brinavess NDA in Q2 2019 Mark H.N. Corrigan, MD to Commence CEO Duties on March 14, 2019 Management to Host Conference...


Mar 11, 2019, 08:00 ET Correvio Announces Amendment To Term Loan With CRG-Managed Funds

Amendment Provides for Up To an Additional $10 Million in Debt Funding NASDAQ: CORV TSX: CORV VANCOUVER, March 11, 2019 /PRNewswire/ - Correvio...


Mar 07, 2019, 08:00 ET Correvio to Present at Upcoming Investor Conferences

NASDAQ: CORV TSX: CORV VANCOUVER, March 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company...


Mar 06, 2019, 08:00 ET Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019

NASDAQ: CORV TSX: CORV Conference Call Scheduled for Wednesday, March 13, 2019 at 8:00 a.m. Eastern (5:00 a.m. Pacific) VANCOUVER, March 6, 2019...


Feb 21, 2019, 08:00 ET Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Feb. 21, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company...


Feb 07, 2019, 08:00 ET Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress

NASDAQ: CORV TSX: CORV VANCOUVER, Feb. 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty...


Jan 17, 2019, 08:00 ET Correvio Provides Update On At The Market Offering

NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 17, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty...


Jan 02, 2019, 08:00 ET Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes

NASDAQ: CORV TSX: CORV – Mark H.N. Corrigan, MD to Succeed William Hunter, MD as Chief Executive Officer by the End of the First Quarter 2019 – – Dr. ...


Nov 20, 2018, 07:00 ET Correvio to Present at the 30th Annual Piper Jaffray Healthcare Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Nov. 20, 2018 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty...


Nov 06, 2018, 16:00 ET Correvio Reports Third Quarter 2018 Financial Results

Management to Host Conference Call and Webcast Today, November 6, 2018 at 4:30 p.m. Eastern (1:30 p.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER, Nov....


Oct 29, 2018, 07:00 ET Correvio Announces Brinavess Eligibility for Patent Extension

Patents May Extend Brinavess' Exclusivity for Use in Atrial Fibrillation Conversion in the U.S. Into 2031 NASDAQ: CORV TSX: CORV VANCOUVER, Oct. 29,...


Oct 23, 2018, 07:00 ET Correvio Announces Intention to Re-File Brinavess® NDA in Second Quarter 2019

NASDAQ: CORV TSX: CORV Pre-NDA Meeting Outlines Path for Brinavess® NDA Resubmission No Additional Studies Required for Resubmission VANCOUVER, Oct....


Sep 20, 2018, 16:01 ET Correvio to Participate In Upcoming Investor Conferences

NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 20, 2018 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty...


Sep 05, 2018, 07:00 ET Correvio Reports Preliminary Data Collected from >2,000 Brinavess® Treatment Episodes in EU Post-Authorization Safety Study

NASDAQ: CORV TSX: CORV Zero Deaths Reported, Safety Outcomes of Interest Observed in 0.8% Cases >70% of AF Episodes Successfully Converted to Sinus...


Sep 04, 2018, 07:00 ET Correvio Highlights Completion of SteadyMed Acquisition by United Therapeutics

NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 4, 2018 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a revenue-generating, specialty...


Aug 28, 2018, 07:00 ET Correvio to Participate in Upcoming Investor Conferences

NASDAQ: CORV TSX: CORV VANCOUVER, Aug. 28, 2018 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ:CORV) (TSX:CORV), a revenue-generating, specialty...


Aug 16, 2018, 07:00 ET Correvio Announces EU Survey Data Demonstrating Brinavess Successfully Avoided Hospitalization in 85% of Patients

NASDAQ: CORV TSX: CORV New Data Used to Support Successful Belgian Reimbursement VANCOUVER, Aug. 16, 2018 /PRNewswire/ - Correvio Pharma Corp....


Aug 14, 2018, 16:00 ET Correvio Reports Second Quarter 2018 Financial Results

Management to Host Conference Call and Webcast Today, August 14, 2018 at 4:30 p.m. Eastern (1:30 p.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER, Aug. ...